The US Department of Defense (DoD) is set to study the PLX-R18 cell therapy product as a treatment for long-term lung injuries caused by mustard gas exposure.

The post US DoD to study PLX-R18 cell therapy to treat mustard gas injuries appeared first on Army Technology.